Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Accenture ( ACN) estimates lowered at Goldman through 2013. Currency changes will likely weigh on earnings. Buy rating and $60 price target.

American Capital ( AGNC) rated new Buy at UBS. $29 price target. Attractive mid to high teens ROE in a low growth environment. Buy rating.

Annaly Capital ( NLY) rated new Neutral at UBS. $17 price target. Outsized exposure to 30 yr fixed mortgage rates raises prepayment risk.

Archer-Daniels-Midland ( ADM) rated new Neutral at Goldman. $30 price target. Company is facing a sharp earnings decline in 2012.

Carmax ( KMX) estimates, target lowered at Credit Suisse. Shares of KMX now seen reaching $36. Estimates also cut, given recent pricing pressure. Outperform rating.

Cavium Networks ( CAVM) target lowered at Morgan Stanley to $48. Cisco's hub transition appears to be happening sooner than expected. Overweight rating.

Cavium Networks downgraded at Deutsche Bank from Buy to Hold. $30 price target. Concerned about near term demand trends and inventory draw downs.

Cavium Networks estimates, target lowered at UBS. Shares of CAVM now seen reaching $37. Estimates also lowered as macro and company issues weigh on 3Q. Buy rating.

CBS ( CBS) target lowered at Kaufman to $27. Syndication revenue could be delayed. Buy rating.

Cepheid ( CPHD) upgraded at Goldman to Buy. New products should continue to drive near-term growth.

Discover Financial Services ( DFS) estimates raised at Evercore to 2012. While beat was mainly driven by improved credit, top line drivers also looked good. Maintain $27 price target and Equal-Weight rating.

Discover Financial Services estimates raised at Sterne Agee through 2013. Expecting only a modest decline in NCOs and will likely see some up tick in NCOs in September or October. Maintain $30 price target and Buy rating.

Dollar Tree ( DLTR) target boosted at Credit Suisse to $65. Company can leverage growth based on its recent investments. Neutral rating.

Dollar Tree estimates, target increased at Jefferies. Shares of DLTR now seen reaching $86. Estimates also raised on strong relative top line growth and its defensive profile. Buy rating.

Edison International ( EIX) rated new Outperform at FBR Capital Market. $41 price target. Company has an attractive regulated utility operation.

FedEx ( FDX) estimates, target lowered at Citigroup. Shares of FDX now seen reaching $87. Estimates also lowered as company lowered its F2012 EPS guidance. Buy rating.

FedEx target lowered at Credit Suisse to $89. Company will likely continue to face macro headwinds. Neutral rating.

FedEx estimates raised at Deutsche Bank through 2013. See compelling value and long term growth potential. Maintain $117 price target and Buy rating.

First Solar ( FSLR) estimates, target cut at Citigroup. Shares of FSLR now seen reaching $90. Estimates also lowered on new merchant pricing reality and lower sales price for Topaz. Hold rating.

First Solar estimates, target cut at UBS. Shares of FSLR now seen reaching $120. Estimates also lowered on near term oversupply and lower sales price for Topaz. Buy rating.

Freeport McMoRan ( FCX) estimates, target lowered at Jefferies. Shares of FCX now seen reaching $55. Estimates also lowered on recent 30 day strike. Buy rating.

Gartner ( IT) rated new Neutral at Credit Suisse. $38 price target. Company is a market leader but is leveraged to a slower macro growth environment.

Hewlett-Packard ( HPQ) numbers cut at Goldman. HPQ estimates were reduced through 2013. Despite the CEO change, the company remains leveraged to slower macro growth. Neutral rating and new $24 price target.

International Rectifier ( IRF) numbers reduced at FBR. Shares of IRF now seen reaching $29. Estimates also cut, as industrial customers appear to be working down inventory. Outperform rating.

Jabil Circuit ( JBL) estimates, target lowered at Deutsche Bank. Shares of JBL now seen reaching $19. Estimates also lowered on a slower growth environment. Hold rating.

Myriad Genetics ( MYGN) upgraded at Goldman from Sell to Neutral. Management's capital deployment has become more progressive.

Nielsen ( NLSN) downgraded at Needham from Buy to Hold. Company has a highly leveraged balance sheet and could be hurt by the European turmoil.

Nike ( NKE) estimates increased at Credit Suisse through 2014. Company continues to generate solid sales growth. Neutral rating and $91 price target.

Nike estimates, target raised at UBS. Shares of NKE now seen reaching $106. Estimates also increased on high quality EPS beat. Maintain Buy rating.

OpenText ( OTEX) upgraded at Benchmark from Sell to Hold. Valuation call, following the recent selloff.

Pandora Media ( P) upgraded at Morgan Stanley from Equal-weight to Overweight. $16 price target. Risk/reward appears more attractive at current levels.

Pepsico ( PEP) downgraded at Stifel from Buy to Hold. Valuation call, as market sentiment has deteriorated in recent months.

PPG Industries ( PPG) rated new Neutral at UBS. $72 price target. An industrial powerhouse at a fair price.

Quest Diagnostics ( DGX) downgraded at Goldman to Sell. Valuation call, as volumes should remain sluggish.

Royal Dutch Shell ( RDS.A) upgraded at Benchmark from Sell to Hold. Valuation call, given the company's solid asset base.

Under Armour ( UA) rated new Buy at Argus Research. $90 price target. Earnings should grow 22% annually over the next five years.

Viacom ( VIA.B) estimates cut at Credit Suisse through 2012. Company now sees lower expected domestic advertising growth. Neutral rating and $41.25 price target.

Viacom estimates lowered at UBS through 2012. Company lowered guidance on ratings issues. Maintain $56 price target and Buy rating.

End of report.
This article was written by a staff member of TheStreet.